Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2007-7-27
pubmed:abstractText
The impact of parathyroidectomy (PTX) on the long-term risks for hip and other fractures is unknown. Uncontrolled case series have reported an increase in bone mineral density after PTX. However, very low serum parathyroid hormone levels have been associated with decreased bone mineral density, adynamic bone disease, and fractures. This study compared long-term fracture rates among hemodialysis patients who underwent PTX with a matched control group. Data were obtained from the US Renal Data System. Patients who underwent a first PTX while receiving hemodialysis were matched with up to three control patients by age, race, gender, year of dialysis initiation, primary cause of renal failure, and the dosage of intravenous vitamin D used before PTX. Patients with a history of fracture or renal transplantation were excluded. Study outcomes were incident hip, vertebral, and distal radius-wrist fractures identified using hospitalization codes. Incident hip fracture rates in the PTX and matched control groups were 6.0 and 9.3 fractures per 1000 person-years, respectively. After adjustment, PTX was associated with a significant 32% lower risk for hip fracture (95% confidence interval 0.54 to 0.86; P = 0.001) and a 31% lower risk for any analyzed fracture (95% confidence interval 0.57 to 0.83; P < 0.001) compared with matched control subjects. Fracture risks were lower among hemodialysis patients who underwent PTX compared with matched control subjects. Surgical amelioration of secondary hyperparathyroidism may outweigh the risk of parathyroid hormone oversuppression in terms of bone health.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1046-6673
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2401-7
pubmed:dateRevised
2007-12-3
pubmed:meshHeading
pubmed-meshheading:17634437-Adult, pubmed-meshheading:17634437-Aged, pubmed-meshheading:17634437-Bone Density Conservation Agents, pubmed-meshheading:17634437-Cohort Studies, pubmed-meshheading:17634437-Databases, Factual, pubmed-meshheading:17634437-Female, pubmed-meshheading:17634437-Fractures, Bone, pubmed-meshheading:17634437-Hip Fractures, pubmed-meshheading:17634437-Humans, pubmed-meshheading:17634437-Hyperparathyroidism, Secondary, pubmed-meshheading:17634437-Incidence, pubmed-meshheading:17634437-Injections, Intravenous, pubmed-meshheading:17634437-Kidney Failure, Chronic, pubmed-meshheading:17634437-Male, pubmed-meshheading:17634437-Middle Aged, pubmed-meshheading:17634437-Parathyroidectomy, pubmed-meshheading:17634437-Radius Fractures, pubmed-meshheading:17634437-Renal Dialysis, pubmed-meshheading:17634437-Risk Factors, pubmed-meshheading:17634437-Spinal Fractures, pubmed-meshheading:17634437-United States, pubmed-meshheading:17634437-Vitamin D
pubmed:year
2007
pubmed:articleTitle
Fracture risk after parathyroidectomy among chronic hemodialysis patients.
pubmed:affiliation
Division of Biostatistics, Harborview Medical Center, University of Washington, Seattle, WA 98104-2499, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural